UPDATE: Pershing Square Files Amended 13D on Allergan, Includes Letter to Allergan's Michael Gallagher

By: via Benzinga
May 19, 2014 By U.S. Mail and Email: Mr. Michael R. Gallagher Lead Director c/o Allergan, Inc. 2525 Dupont Drive ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.